Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
Saved in:
| Published in | ANNALS OF ONCOLOGY Vol. 33; no. 7; p. S1408 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Conference Proceeding |
| Language | English |
| Published |
2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Author | Fernandez, AM Dummer, R Ferrucci, PF Ferraresi, V Guida, M Richtig, E Giannarelli, D Melero, I Palmieri, G Gogas, HJ Ascierto, PA Rutkowski, P Helgadottir, H Grimaldi, AM Sileni, VC Maiello, E Fierro, MT Mandala, M Guidoboni, M Lebbe, C |
|---|---|
| Author_xml | – sequence: 1 givenname: PA surname: Ascierto fullname: Ascierto, PA – sequence: 2 givenname: M surname: Mandala fullname: Mandala, M – sequence: 3 givenname: PF surname: Ferrucci fullname: Ferrucci, PF – sequence: 4 givenname: M surname: Guidoboni fullname: Guidoboni, M – sequence: 5 givenname: P surname: Rutkowski fullname: Rutkowski, P – sequence: 6 givenname: V surname: Ferraresi fullname: Ferraresi, V – sequence: 7 givenname: AM surname: Fernandez fullname: Fernandez, AM – sequence: 8 givenname: M surname: Guida fullname: Guida, M – sequence: 9 givenname: E surname: Maiello fullname: Maiello, E – sequence: 10 givenname: HJ surname: Gogas fullname: Gogas, HJ – sequence: 11 givenname: E surname: Richtig fullname: Richtig, E – sequence: 12 givenname: MT surname: Fierro fullname: Fierro, MT – sequence: 13 givenname: C surname: Lebbe fullname: Lebbe, C – sequence: 14 givenname: H surname: Helgadottir fullname: Helgadottir, H organization: Karolinska Institutet – sequence: 15 givenname: I surname: Melero fullname: Melero, I – sequence: 16 givenname: G surname: Palmieri fullname: Palmieri, G – sequence: 17 givenname: D surname: Giannarelli fullname: Giannarelli, D – sequence: 18 givenname: AM surname: Grimaldi fullname: Grimaldi, AM – sequence: 19 givenname: R surname: Dummer fullname: Dummer, R – sequence: 20 givenname: VC surname: Sileni fullname: Sileni, VC |
| BackLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:151333737$$DView record from Swedish Publication Index |
| BookMark | eNqli81OwzAQhH0oEi3wBhz2CIcYO0lbwpGqqDmgIrX3aNMs1G1sB_-AcuTNCdA3QKPRjEbzTdjIWEOMXUvBpZCzuwNHM0w7noo05eKei1yM2FgUaZbMp1l-zibeH4QQsyItxuzrZY-eoCzBh9j0sFku1s-P5RZuPL1HMkFhCzurawtK62gsoGkgoHujAGFPDrv-D719gDzpCZ2H9QYaDPh77Ry1SiuDrodaWY3uSMOFPrCNGJQ1l-zsFVtPV6e8YMXTcrtYJf6TulhXnVMD1FcW1dBtU532o_px5amSU5ll2XzQf9hvj3tqbg |
| ContentType | Conference Proceeding |
| DBID | ADTPV BNKNJ BVBDO D8T |
| DOI | 10.1016/j.annonc.2022.08.040 |
| DatabaseName | SwePub SwePub Conference SwePub Conference full text SWEPUB Freely available online |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | oai_prod_swepub_kib_ki_se_151333737 |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0SF 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AAEDW AAJKP AAJQQ AAKAS AAKUH AALRI AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEYI ADHKW ADHZD ADJQC ADOCK ADRIX ADRTK ADTPV ADVLN ADYVW ADZCM ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFETI AFIYH AFJKZ AFOFC AFSHK AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASPBG ATTQO AVWKF AXUDD AZFZN BAWUL BAYMD BGNMA BHONS BNKNJ BTRTY BVBDO BVRKM BZKNY C1A CAG CDBKE CKLRP COF CS3 CZ4 D8T DAKXR DIK DILTD DL5 D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 |
| ID | FETCH-swepub_primary_oai_prod_swepub_kib_ki_se_1513337373 |
| ISSN | 0923-7534 |
| IngestDate | Wed Oct 23 03:55:26 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-swepub_primary_oai_prod_swepub_kib_ki_se_1513337373 |
| OpenAccessLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:151333737 |
| ParticipantIDs | swepub_primary_oai_prod_swepub_kib_ki_se_151333737 |
| PublicationCentury | 2000 |
| PublicationDate | 2022 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – year: 2022 text: 2022 |
| PublicationDecade | 2020 |
| PublicationTitle | ANNALS OF ONCOLOGY |
| PublicationYear | 2022 |
| SSID | ssj0006929 |
| Score | 4.4467664 |
| SourceID | swepub |
| SourceType | Open Access Repository |
| StartPage | S1408 |
| SubjectTerms | Medicin och hälsovetenskap |
| Title | Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation |
| URI | http://kipublications.ki.se/Default.aspx?queryparsed=id:151333737 |
| Volume | 33 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUKSIgbSxG7fAAJFAVRZ6u50YolQGmlFsQtirOIQklQl0O5wZczXpoE2gNwiBWltlN5Xj329M0zQvuURI7FYJsahDHVTcc_0X1iET2qxjGx46Bii6y0xp19dW9eP1qPpdJngbU0GrLj4H1mXsl_rArPwK48S_YPls06hQdwD_aFEiwM5bSNZ7qaszvOvuPUnSbszvP_hOSnrSfwUZrrShFZrX1ebzZqboevKiWFetgV8iCvLNW6PFEklYRKwQ7XZGrWWDY-IJQHD0x9DD-NgdZsa5xbOpEZ6ImzwfpjjWfzc8IPVMl1xDNQcXfbF-c2TYJ_IhaehH7P_xaZvYj6gLlAMA1aGff4ctQNU5aKQ6hUXRWvIKQQr1CBR2LosEkyi3OwFMNQWHMKE2obNoDVmVO9jDo8H_tJkiZcjJIQIcYq1Z9miGhzj-RJOVjvpcsvbxB5FX7AjeEYzhxaIAa1YGZcOKs93Nxm_tymRCo2qu89ScAULMHpt__QnBXrlM4yKucZnLiVAWYFlaJkFS02FJFiDX0IaGDXxcK6eAINfJgDAwtgYAkMDFbCEhhYAUM2PTrFChS42cYcFKJqARQ4BwXOQVFG9OK8U7_S1Vi9SdkT7xdjaKyjeRiPaANh2w59yiqUGZSZNjthcUyDIAqhMJnFnE1E_t7_1n8abaOlHIc7aH7YH0W7sJIcsj1l6i-m8oFy |
| link.rule.ids | 230,310,311,786,790,795,796,891,4069,4070,23958,23959,25170,27956 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=ANNALS+OF+ONCOLOGY&rft.atitle=Phase+II+study+SECOMBIT+%28sequential+combo+immuno+and+target+therapy+study%29%3A+4-years+OS+data+and+preliminary+biomarkers+evaluation&rft.au=Ascierto%2C+PA&rft.au=Mandala%2C+M&rft.au=Ferrucci%2C+PF&rft.au=Guidoboni%2C+M&rft.date=2022-01-01&rft.issn=0923-7534&rft.volume=33&rft.issue=7&rft.spage=S1408&rft_id=info:doi/10.1016%2Fj.annonc.2022.08.040&rft.externalDocID=oai_prod_swepub_kib_ki_se_151333737 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |